Zobrazeno 1 - 10
of 298
pro vyhledávání: ''
Autor:
Neha Goel, Joshua P. Kronenfeld, Sophia Liu, Susan B. Kesmodel, Caroline K. Fiser, Wrood Kassira, John C. Oeltjen
Publikováno v:
Clin Breast Cancer
BACKGROUND: Skin-sparing (SSM) and nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) have significantly increased. There is limited information on complications of IBR in patients with prior cosmetic breast surgery (CBS). We
Autor:
Larisa M. Haupt, Gabrielle Bradshaw, K.M. Taufiqul Arif, Rachel K. Okolicsanyi, Philippa H. Youl, Robert A. Smith, Thanh Tan Nguyen, Lyn R. Griffiths
Publikováno v:
Clinical Breast Cancer. 21:e694-e703
Introduction Breast cancer (BC), a heterogeneous disease, features microRNA-related single nucleotide polymorphisms (miRSNPs) as underlying factors of BC development, thus providing targets for novel diagnostic and therapeutic strategies. This study
Publikováno v:
Clin Breast Cancer
We investigated whether our convolutional neural network-based breast cancer risk model is modifiable by testing it on women who had undergone risk-reducing treatment with known chemoprevention agents. Compared with baseline, significantly more women
Autor:
Giacomo Montagna, Monica Morrow
Publikováno v:
Clinical Breast Cancer. 21:112-119
Radiotherapy (RT) after breast-conserving surgery (BCS) halves the risk of local recurrence, and it is considered the standard of care for the vast majority of patients with early invasive breast cancer. However, the majority of patients treated with
Autor:
Julia Frebault, Carmen Bergom, Chandler S. Cortina, Monica E. Shukla, Yiwen Zhang, Chiang-Ching Huang, Amanda L. Kong
Publikováno v:
Clinical breast cancer. 22(6)
Despite an aging population, there are no established treatment guidelines for women with ductal carcinoma in situ (DCIS) age ≥80. Here we describe national treatment patterns and survival outcomes in older women with DCIS.Women age ≥80 diagnosed
Autor:
Bethany Anderson, Heather B. Neuman, Roberta M. Strigel, Amy L. Stella, Erin Bravo, Amye J. Tevaarwerk
Publikováno v:
Clin Breast Cancer
Limited data exist to guide appropriate use of magnetic resonance imaging (MRI) screening in women with a personal history of breast cancer. We developed an algorithm to inform the use of MRI screening in patients with a personal history, implemented
Autor:
Susan Abughosh, Meghana V. Trivedi, Kelvin Lu, Rutugandha Paranjpe, Carine Opsomer, Hanna Zaghloul, Grace S. Hwang, Uzoamaka Abajue
Publikováno v:
Clinical Breast Cancer. 20:520-526
Introduction Adherence to oral endocrine therapy (OET) reduces recurrence risk for hormone receptor (HR)-positive breast cancer (BC). Refill data accessed through electronic health records may provide objective assessment of OET adherence. Our goal w
Autor:
Shishi Zhou, Wanfen Tang, Xifeng Xu, Xiayun Jin, Chenyang Ge, Jianfei Fu, Xia Zhang, Jinlin Du, Hongjuan Zheng, Haiping Lin, Qinghua Wang
Publikováno v:
Clinical Breast Cancer. 20:503-510
Background We conducted this study to evaluate whether patients with T1a/b, node-negative (N−), human epidermal growth factor receptor 2-positive (HER2+) breast cancers benefited from adjuvant therapy, and explored better treatment strategies for t
Publikováno v:
Clinical Breast Cancer. 20:469-479
Whole breast radiation therapy (RT) has become standard of care in early stage breast cancer treatment following lumpectomy. Predictors of RT completion have been sparsely studied, with no previous nationwide examination of the impact of fractionatio
Autor:
Davide Franceschini, Stefano Tomatis, Pierina Navarria, Corrado Tinterri, Antonella Fogliata, Elena Clerici, Mauro Loi, Fiorenza De Rose, Marta Scorsetti, Ciro Franzese, Tiziana Comito, Alberto Testori, Luca Cozzi, Giuseppe D'Agostino, Lucia Di Brina, Francesca Lobefalo, Wolfgang Gatzemeier, Cristina Iftode
Publikováno v:
Clinical Breast Cancer. 20:527-533
Introduction The purpose of this study was to evaluate the impact of breast size on long-term toxicity and cosmesis in patients with breast cancer treated with hypofractionated simultaneous integrated boost (SIB) using volumetric modulated arc therap